How should I administer 31 units of regular insulin over a 4‑hour period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of 31 Units of Regular Insulin Over 4 Hours

For transitioning from intravenous to subcutaneous insulin after receiving 31 units over 4 hours (approximately 7.75 units/hour), administer half the total IV dose (approximately 15-16 units) as long-acting basal insulin immediately upon stopping the IV infusion, with the remaining half divided as rapid-acting insulin doses with meals. 1

Transition Protocol from IV to Subcutaneous Insulin

Timing and Prerequisites

  • Ensure blood glucose stability below 180 mg/dL (10 mmol/L) for at least several hours before transitioning 1
  • Stop IV insulin only when the hourly infusion rate is ≤0.5 units/hour; if the rate is ≥5 units/hour, this indicates major insulin resistance and the IV should remain in place 1
  • Resume oral feeding before making the transition to subcutaneous insulin 1

Dose Calculation Based on 31 Units Over 4 Hours

Standard approach (50/50 split):

  • Basal insulin: 15-16 units of long-acting insulin (detemir, glargine, or degludec) given immediately after stopping IV insulin 1
  • Prandial insulin: Remaining 15-16 units divided among meals as rapid-acting insulin (aspart, lispro, or glulisine) 1

Alternative approach (80/20 split):

  • Some protocols recommend 80% of the IV dose (approximately 25 units) as basal insulin with rapid-acting insulin added at the first meal 1
  • This approach may be preferred when insulin requirements are high or insulin resistance is present 1

Practical Administration Steps

For basal insulin:

  • Inject immediately after discontinuing the IV insulin infusion to prevent rebound hyperglycemia 1
  • Optimal timing is 20:00 hours (8 PM); if transitioning earlier, adjust the dose proportionally and give a second injection at 20:00 hours 1

For prandial insulin:

  • Administer rapid-acting insulin before each meal, adjusting doses based on carbohydrate content 1
  • Initial prandial doses: Divide the remaining insulin equally among three meals (approximately 5 units per meal if using 50/50 split) 1
  • Reduce prandial dose by 50% if the meal is light or carbohydrate intake is minimal 1

Monitoring and Safety Considerations

Hypoglycemia Prevention

  • Monitor blood glucose every 2-4 hours initially after transition 1
  • Treat hypoglycemia (<70 mg/dL) immediately by stopping insulin and administering 10-20 grams of IV dextrose (50% solution), titrated to avoid overcorrection 1
  • For mild hypoglycemia (70-100 mg/dL with symptoms), administer 15-20 grams of oral glucose 1
  • Recheck glucose 15 minutes after treatment and repeat if needed 1

Dose Adjustments

  • If hypoglycemia occurs without clear cause, reduce the corresponding insulin dose by 10-20% 1
  • For persistent hyperglycemia (>180 mg/dL), add supplemental rapid-acting insulin in 2-4 unit increments 1
  • Titrate basal insulin by 2 units every 3 days to reach fasting glucose goals without hypoglycemia 1

Common Pitfalls to Avoid

  • Never stop IV insulin without immediately administering subcutaneous basal insulin, as this creates a dangerous gap in insulin coverage leading to rapid hyperglycemia 1
  • Do not use sliding scale insulin alone in patients previously requiring continuous IV insulin, as this approach is associated with poor glycemic control and increased complications 1
  • Avoid transitioning if the IV insulin rate exceeds 3 units/hour, as this indicates high risk for postoperative complications and inadequate subcutaneous insulin absorption 1
  • Do not underdose glucose when giving insulin; administer at least 50 grams of glucose with 10 units of insulin to prevent hypoglycemia 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.